The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We ...
Major bleeding occurred in one patient (0.2%) in each group. At the end of follow-up, 14 patients in the fondaparinux group (3.3%) and 25 in the placebo group (6.0%) had died. Conclusion Fondaparinux ...
A safe, effective antithrombotic agent is needed for patients with acute ST-segment elevation myocardial infarction (STEMI) as the associated mortality is still unacceptably high. The international, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback